Correlation Between OVERSEA CHINUNSPADR2 and Genertec Universal

Can any of the company-specific risk be diversified away by investing in both OVERSEA CHINUNSPADR2 and Genertec Universal at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OVERSEA CHINUNSPADR2 and Genertec Universal into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between OVERSEA CHINUNSPADR2 and Genertec Universal Medical, you can compare the effects of market volatilities on OVERSEA CHINUNSPADR2 and Genertec Universal and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OVERSEA CHINUNSPADR2 with a short position of Genertec Universal. Check out your portfolio center. Please also check ongoing floating volatility patterns of OVERSEA CHINUNSPADR2 and Genertec Universal.

Diversification Opportunities for OVERSEA CHINUNSPADR2 and Genertec Universal

0.35

Correlation Coefficient

OVERSEA CHINUNSPADR2  Genertec Universal

Weak diversification

The 3 months correlation between OVERSEA and Genertec is 0.35. Overlapping area represents the amount of risk that can be diversified away by holding OVERSEA CHINUNSPADR2 and Genertec Universal Medical in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Genertec Universal and OVERSEA CHINUNSPADR2 is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OVERSEA CHINUNSPADR2 are associated (or correlated) with Genertec Universal. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Genertec Universal has no effect on the direction of OVERSEA CHINUNSPADR2 i.e., OVERSEA CHINUNSPADR2 and Genertec Universal go up and down completely randomly.

Pair Corralation between OVERSEA CHINUNSPADR2 and Genertec Universal

Assuming the 90 days trading horizon OVERSEA CHINUNSPADR2 is expected to generate 0.27 times more return on investment than Genertec Universal. However, OVERSEA CHINUNSPADR2 is 3.72 times less risky than Genertec Universal. It trades about 0.21 of its potential returns per unit of risk. Genertec Universal Medical is currently generating about -0.01 per unit of risk. If you would invest  2,060  in OVERSEA CHINUNSPADR2 on October 7, 2024 and sell it today you would earn a total of  260.00  from holding OVERSEA CHINUNSPADR2 or generate 12.62% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Together
Strength	Very Weak
Accuracy	100.0%
Values	Daily Returns

OVERSEA CHINUNSPADR2  vs.  Genertec Universal Medical

OVERSEA CHINUNSPADR2

Risk-Adjusted Performance

16 of 100

Solid

Compared to the overall equity markets, risk-adjusted returns on investments in OVERSEA CHINUNSPADR2 are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak fundamental drivers, OVERSEA CHINUNSPADR2 may actually be approaching a critical reversion point that can send shares even higher in February 2025.

Genertec Universal

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days Genertec Universal Medical has generated negative risk-adjusted returns adding no value to investors with long positions. Despite nearly stable basic indicators, Genertec Universal is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.

Pair Trading with OVERSEA CHINUNSPADR2 and Genertec Universal

The main advantage of trading using opposite OVERSEA CHINUNSPADR2 and Genertec Universal positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OVERSEA CHINUNSPADR2 position performs unexpectedly, Genertec Universal can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Genertec Universal will offset losses from the drop in Genertec Universal's long position.

The idea behind OVERSEA CHINUNSPADR2 and Genertec Universal Medical pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.